[go: up one dir, main page]

AU8768098A - Method of treating disease using a tocotrienol and alpha-lipoic acid r derivatives or an ester thereof - Google Patents

Method of treating disease using a tocotrienol and alpha-lipoic acid r derivatives or an ester thereof

Info

Publication number
AU8768098A
AU8768098A AU87680/98A AU8768098A AU8768098A AU 8768098 A AU8768098 A AU 8768098A AU 87680/98 A AU87680/98 A AU 87680/98A AU 8768098 A AU8768098 A AU 8768098A AU 8768098 A AU8768098 A AU 8768098A
Authority
AU
Australia
Prior art keywords
tocotrienol
alpha
derivatives
ester
lipoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87680/98A
Inventor
Christopher J. Berry
John L. Foley
Lester Packer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHRISOTPHER J BERRY
Original Assignee
CHRISOTPHER J BERRY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHRISOTPHER J BERRY filed Critical CHRISOTPHER J BERRY
Publication of AU8768098A publication Critical patent/AU8768098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU87680/98A 1997-08-04 1998-08-04 Method of treating disease using a tocotrienol and alpha-lipoic acid r derivatives or an ester thereof Abandoned AU8768098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5543397P 1997-08-04 1997-08-04
US60055433 1997-08-04
PCT/US1998/016207 WO1999006040A1 (en) 1997-08-04 1998-08-04 Method of treating disease using a tocotrienol and alpha-lipoic acid or derivatives or an ester thereof

Publications (1)

Publication Number Publication Date
AU8768098A true AU8768098A (en) 1999-02-22

Family

ID=21997763

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87680/98A Abandoned AU8768098A (en) 1997-08-04 1998-08-04 Method of treating disease using a tocotrienol and alpha-lipoic acid r derivatives or an ester thereof

Country Status (2)

Country Link
AU (1) AU8768098A (en)
WO (1) WO1999006040A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786104B1 (en) 1998-11-25 2002-12-27 Centre Nat Rech Scient INHIBITORS OF NF-KB ACTIVATION, AND THEIR PHARMACEUTICAL USES
US6284786B1 (en) * 1999-02-16 2001-09-04 The Center For The Improvement Of Human Functioning, Int'l., Inc. Treatment of cancer using lipoic acid in combination with ascorbic acid
FR2791571B1 (en) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic ASSOCIATION OF NO SYNTHASE INHIBITOR (S) AND METABOLIC ANTIOXIDANT (S)
IT1312060B1 (en) * 1999-04-09 2002-04-04 Antibioticos Spa USE OF ALPHA LIPOIC ACID IN ANTIMETASTATIC TREATMENT.
WO2000078296A2 (en) * 1999-06-17 2000-12-28 Basf Aktiengesellschaft Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
DE19941217A1 (en) * 1999-08-30 2001-03-15 Asta Medica Ag Treatment of migraines by administration of alpha-lipoic acid or derivatives thereof
JP2001342133A (en) * 2000-03-31 2001-12-11 Eisai Co Ltd gamma-TOCOTRIENOL-CONTAINING DIURETIC
EP1270004B1 (en) * 2000-03-31 2010-06-09 Eisai R&D Management Co., Ltd. Use of gamma-tocotrienol as diuretic
DE10027968A1 (en) * 2000-06-08 2001-12-13 Asta Medica Ag Adjuvant therapy of dementia using alpha-lipoic acid or derivative, is effective in combination with antidementia or neurotransmission improving agents in improving cognitive function in e.g. Alzheimer's disease patients
DE20203244U1 (en) 2002-03-01 2002-05-23 Meins, Wolfgang, Prof. Dr., 22391 Hamburg Pharmaceutical composition for the prevention of Alzheimer's dementia
US20040034093A1 (en) * 2002-05-30 2004-02-19 Hensley Kenneth L. Methods for enhancing motor performance and/or endurance
RU2325908C1 (en) * 2006-09-20 2008-06-10 Государственное учреждение научно-исследовательский институт онкологии Томского Научного центра Сибирского отделения Российской академии медицинских наук (ГУ НИИ онкологии ТНЦ СО РАМН) Method of complication prevention accompanying combinatorial treatment of lung and venter cancer
DE102007038849A1 (en) 2007-08-16 2009-02-19 Adscil Gmbh Use of R (+) - alpha lipoic acid for the treatment of cryptogenic neuropathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
WO1993009777A1 (en) * 1991-11-22 1993-05-27 Lipogenics, Inc. Tocotrienols and tocotrienol-like compounds and methods for their use

Also Published As

Publication number Publication date
WO1999006040A1 (en) 1999-02-11
WO1999006040A9 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
AU4024295A (en) Amino acid derivatives of paclitaxel
AU9028798A (en) Method of improving drug treatment
AU6589798A (en) Ileus treatment method
AU8672398A (en) Method of laser surgery
AU7164198A (en) Method of preparing salicyloylamino acids
AU6046998A (en) Method of measuring physiological function
AU8768098A (en) Method of treating disease using a tocotrienol and alpha-lipoic acid r derivatives or an ester thereof
AU4161797A (en) Benzoperimidine-carboxylic acids and derivatives thereof
HUP9801156A3 (en) Carbapenem-3-carboxylic acid ester derivatives
PL338579A1 (en) Method of increasing bioavailability of phexophenadin and its derivatives
AU3471995A (en) Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU6986496A (en) Retinoylamide based derivatives of sphingoid bases
AUPO359396A0 (en) A method of treatment and pharmaceutical compositions useful for same
AU2645497A (en) Thio derivatives of hydroxamic acids
AU4547896A (en) 4-oxo-2-butenoic acid derivatives
IL125043A0 (en) Iminooxyphenylacetic acid derivatives method and intermediates for their preparation and their use
AU8817398A (en) Method of drug selection
AU9344298A (en) Method of producing substituted 2-nitroguanidine derivatives
AU9247698A (en) Method for the identification of essential genes and therapeutic targets
AU1466897A (en) Method of stabilizing odors in manure
IL119306A0 (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives and their preparation
PL339304A1 (en) Method of obtaining derivatives of 1-phenylparazolin-3-carboxylic acid
PL335373A1 (en) Method of obtaining derivatives of 4h-4-oxoquinolysine-3-carboxylic acid
PL326699A1 (en) Method of obtaining derivatives of 3-phenyl-1-methylenedioxyphenyl-indane 2-carboxylic acids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase